The plastic surgery industry has become one of the most resilient and fastest-evolving segments of American healthcare, and the numbers behind it tell a compelling story for practice owners and investors alike. Whether you run an established surgical center or you are planning to open your first aesthetic practice, understanding the latest plastic surgery statistics is the foundation of every smart growth decision, from hiring and marketing to equipment purchases and facility expansion.
In this report, we break down the most important plastic surgery practice statistics for 2026: market size, procedure volume, patient demographics, revenue benchmarks, and the real costs of running a modern aesthetic practice. We also connect each data point to the financing decisions that practice owners face every day, because knowing the numbers is only useful when you know how to act on them.
At Crestmont Capital, we work with plastic surgeons and aesthetic medicine practices across the country, and we see firsthand how the right funding turns industry growth into practice growth. Let us start with the big picture.
In This Article
The American plastic surgery market has grown steadily for more than a decade, and 2026 is shaping up to be another record year. Industry analysts estimate the U.S. cosmetic surgery and aesthetics market at roughly $20 billion to $27 billion annually, with the broader medical aesthetics segment, including non-surgical treatments, pushing the total opportunity even higher. Demand is driven by a combination of cultural acceptance of cosmetic procedures, social media visibility, an aging population seeking rejuvenation, and a steady stream of new technology that makes treatments safer and less invasive.
According to procedural statistics published by the American Society of Plastic Surgeons, Americans undergo well over 25 million cosmetic procedures each year when surgical and minimally invasive treatments are combined. Minimally invasive procedures such as botulinum toxin injections, dermal fillers, and laser treatments account for the overwhelming majority of that volume, and they are also the fastest-growing revenue lines for most practices.
For practice owners, the headline takeaway is simple: demand is not the problem. The constraint on growth for most aesthetic practices is capacity, and capacity costs money. Treatment rooms, surgical suites, lasers, imaging systems, and skilled staff all require capital, which is exactly where plastic surgery practice financing enters the picture.
Key Stat: The American Society of Plastic Surgeons reports that minimally invasive cosmetic procedures have grown by more than 200% since 2000, and the non-surgical segment continues to outpace surgical growth year after year.
Demographics are widening the market as well. Patients aged 40 to 54 remain the largest cohort for surgical procedures, but patients under 30 are the fastest-growing group for injectables and skin treatments. Men now account for a meaningful and rising share of cosmetic procedures, a segment that barely existed two decades ago. Practices that position themselves to serve these expanding demographics, with the right equipment and the right space, are capturing outsized revenue growth.
Below are the plastic surgery industry statistics that matter most for practice owners planning investments in 2026. Figures are drawn from publicly reported industry data, procedural statistics releases, and market research estimates.
Market size and growth:
Procedure volume:
Practice economics:
These figures explain both the opportunity and the capital intensity of the specialty. Plastic surgery is a high-revenue field, but it is also one where staying competitive requires continuous reinvestment in technology, facilities, and talent.
Statistics are only useful when they inform decisions. For a plastic surgery practice owner, the 2026 data points to three practical conclusions.
First, the growth is in non-surgical services. Injectables, laser treatments, and skin rejuvenation are expanding far faster than traditional surgery. That means the practices winning market share are the ones adding treatment rooms, hiring injectors, and buying energy-based devices. Each of those moves requires capital, often $100,000 to $300,000 for a meaningful expansion.
Second, patient expectations are rising. Patients comparing practices online expect modern facilities, the latest technology, and a polished experience from consultation to recovery. A dated office or an aging device fleet quietly costs you patients every month. Cosmetic surgery statistics consistently show that practices investing in patient experience and new technology grow faster than those that defer investment.
Third, timing matters more than price. When a competitor two miles away adds a new body-contouring platform and starts marketing it aggressively, waiting 18 months to save up the cash to respond is a losing strategy. Financing lets you move at the speed of the market instead of the speed of your bank account.
By the Numbers
Plastic Surgery Practice Financing - Key Statistics for 2026
$25B+
Estimated U.S. cosmetic surgery and aesthetics market size
25M+
Minimally invasive cosmetic procedures performed each year
$400K
Typical cost to build out an accredited surgical suite
10-15%
Projected annual growth of the non-surgical aesthetics segment
Before you can plan financing, you need an honest picture of where the money goes. Plastic surgery practices carry a cost structure that surprises many surgeons coming out of residency or leaving a hospital-employed position.
Facility costs are usually the largest fixed expense. Medical office space in desirable markets runs $25 to $60 per square foot annually, and an accredited surgical suite adds build-out costs of $250,000 to $500,000 before you see a single patient. Accreditation, anesthesia equipment, monitoring systems, and backup power all add to the total.
Equipment costs never really stop. A competitive aesthetic practice typically needs surgical instruments and operating room equipment, one or more laser or energy-based platforms at $50,000 to $150,000 each, body-contouring devices, imaging and photography systems, and practice management software. Technology cycles in aesthetics run five to seven years, so equipment financing is a recurring line item, not a one-time event.
Staffing costs scale with growth. Aesthetic nurses, injectors, medical assistants, front-desk staff, and a practice manager can easily total $500,000 to $1 million or more per year for a mid-size practice. Payroll has to be met every two weeks regardless of when insurance reimbursements or patient payments arrive.
Marketing costs are the price of visibility. In most metros, practices spend 5% to 10% of revenue on digital marketing, and cosmetic surgery statistics show that patients increasingly choose providers based on online reviews, before-and-after galleries, and social media presence.
Pro Tip: Add up your full equipment wish list for the next 24 months, not just the next purchase. Financing several devices in one facility or term loan is almost always cheaper per dollar than stacking multiple small loans, and it simplifies your monthly obligations into one predictable payment.
The pattern across all four categories is the same: costs arrive before revenue does. That timing gap is exactly what practice financing is designed to bridge.
Ready to Invest in Your Practice?
Get fast, flexible financing from the #1 business lender in the U.S. No obligation - apply in minutes.
Apply Now →Practice financing is simpler than most surgeons expect. While every lender structures deals a little differently, the process at Crestmont Capital follows the same basic path whether you are borrowing $50,000 for a single laser or $2 million for a full surgical center build-out.
Step 1: Define the use of funds. Lenders want to know what the money will do for the practice. Equipment purchases, build-outs, working capital, marketing campaigns, and acquisitions are all common and well-understood uses. A clear use of funds leads to a faster approval.
Step 2: Apply with basic documentation. A typical application requires a short form plus recent bank statements. Larger facilities may also ask for tax returns, a profit-and-loss statement, or an equipment quote. The U.S. Small Business Administration reports that streamlined alternative lenders can often decision applications in days rather than the weeks or months a traditional bank may take.
Step 3: Review terms and choose a structure. You will see offers with different term lengths, rates, and payment schedules. The right choice depends on the asset: long-lived assets like a surgical suite suit longer terms, while fast-depreciating devices usually belong on shorter schedules.
Step 4: Funding. Once documents are signed, funds are disbursed to you or directly to the equipment vendor. Many of the practices we work with go from application to funded in a matter of days.
That is the entire process. The rest of this section breaks down the specific financing types you will encounter and when each one makes sense.
Different investments call for different structures. Here are the five financing types that cover nearly every funding need in an aesthetic practice, along with the situations where each one performs best.
Equipment financing. A loan or lease secured by the equipment itself. Because the device serves as collateral, approvals are often faster and rates lower than unsecured options. This is the natural fit for lasers, body-contouring platforms, surgical equipment, and imaging systems. Crestmont Capital offers dedicated medical equipment financing designed around the devices aesthetic practices actually buy.
Term loans. A lump sum repaid over a fixed schedule, typically one to ten years. Term loans suit build-outs, renovations, and acquisitions where you need a defined amount for a defined project. SBA loans fall into this family and offer attractive rates for qualified borrowers willing to work through a longer application process.
Working capital loans. Shorter-term funding for operating expenses: payroll, marketing, inventory like injectables and skincare products, or bridging seasonal slowdowns. Working capital loans are built for speed and flexibility rather than long amortizations.
Business lines of credit. A revolving facility you draw on as needed and repay as you go. A business line of credit is ideal for expenses you cannot schedule in advance, like a device repair, a marketing opportunity, or a gap between a big supply order and the revenue it generates.
Commercial real estate financing. For practices ready to buy their building instead of leasing. Owning your facility converts rent into equity and gives you complete control over build-outs and expansion.
| Financing Type | Best For | Typical Term | Speed to Fund |
|---|---|---|---|
| Equipment financing | Lasers, devices, surgical equipment | 2-7 years | Days |
| Term loan (incl. SBA) | Build-outs, acquisitions, expansion | 1-10 years | Days to weeks |
| Working capital loan | Payroll, marketing, inventory | 6-24 months | Days |
| Business line of credit | Ongoing or unexpected expenses | Revolving | Days |
| Commercial real estate financing | Buying your practice facility | 10-25 years | Weeks |
Most growing practices end up using two or three of these at once. A common combination is equipment financing for devices, a line of credit for flexibility, and a term loan for the facility project.
Surgeons are trained to minimize risk, which makes many of them instinctively cautious about borrowing. But in a market growing as fast as this one, strategic financing is usually the lower-risk path. The core benefits:
The common thread: financing converts a large, lumpy capital expense into a predictable monthly cost that scales with the revenue the investment generates.
Qualification standards vary by product and lender, but the core factors are consistent across the industry.
Time in business. Most programs want at least six months to two years of operating history. Established practices with two or more years of revenue qualify for the broadest range of options. Newer practices are not excluded; startup-friendly programs exist, though they lean more heavily on the surgeon's personal credit and credentials.
Revenue. Lenders look at monthly deposits as the primary measure of capacity. A practice collecting $80,000 or more per month can typically support meaningful financing. Higher revenue unlocks larger facilities and better pricing.
Credit. A personal credit score in the mid-600s or better opens most doors, and scores above 700 command the best rates. Medical practices often qualify more easily than other industries at the same score because lenders view healthcare revenue as unusually stable.
Documentation. Recent bank statements are the baseline. Larger facilities may add tax returns, financial statements, and an equipment quote or project budget.
Key Stat: Healthcare and social assistance businesses consistently rank among the largest recipients of small business lending in the United States, and lenders report lower default rates on medical practice loans than on most other small business categories.
If your practice is newer or your credit has a few dings, do not assume you are out of options. Equipment financing in particular is accessible because the equipment itself secures the deal.
Every growth investment ultimately gets funded one of three ways: cash from reserves, financing, or leasing (in the case of equipment). Here is how they compare in practice.
Cash costs nothing in interest and keeps the balance sheet clean. The tradeoffs are real, though: it drains reserves you may need, it caps how many projects you can pursue at once, and it moves at the speed of your savings rate. In a segment growing 10% to 15% per year, slow is expensive.
Financing preserves cash, matches cost to benefit, and lets you own the asset at the end. The cost is interest, and for strong borrowers that cost is modest relative to the revenue a new service line produces. A $120,000 laser generating $40,000 per month in treatments does not need to be paid for in cash to be an excellent investment.
Leasing minimizes upfront cost and keeps you on the newest technology, which matters in a device category where platforms improve every few years. You will generally pay more over the full period than with a purchase, and you do not build equity in the device unless the lease includes a buyout.
The right answer is usually a blend: finance the long-lived assets, lease the fast-cycle technology, and hold cash for the opportunities you cannot predict. Publications like Forbes and CNBC have covered how healthcare practices increasingly treat financing as a strategic tool rather than a last resort, and the most successful aesthetic practices we work with think exactly that way.
Crestmont Capital is rated the #1 business lender in the U.S., and medical and aesthetic practices are one of the industries we know best. We fund the full range of practice needs: surgical equipment, lasers and energy devices, facility build-outs, working capital, and practice acquisitions.
What sets us apart for plastic surgery practices specifically:
If you are earlier in your research, our companion guide to plastic surgery practice loans walks through loan structures and qualification in more depth. Practice owners in adjacent wellness specialties can also see how the numbers compare in our massage therapy practice financing statistics report.
Get a Funding Decision in Hours
Join the thousands of practices that trust Crestmont Capital for fast, flexible financing. Apply in minutes with no obligation.
Apply Now →Statistics and loan structures make more sense in context. Here are five scenarios drawn from the situations aesthetic practices actually face, and how financing solves each one.
Scenario 1: The new laser. A two-surgeon practice in Dallas wants to add a $130,000 body-contouring platform. Patient demand is clear - the practice fields weekly inquiries about the treatment - but paying cash would consume most of its operating reserve. Equipment financing over 48 months puts the payment around $3,000 per month, while conservative projections show the device generating $25,000 to $35,000 per month in new revenue. The asset pays for itself many times over.
Scenario 2: The build-out. A surgeon leaving hospital employment is opening her own practice. The surgical suite build-out, accreditation, and equipment total $600,000. A combination of a term loan for the build-out and equipment financing for the devices spreads the cost across seven years, keeping payments manageable while the patient base ramps up.
Scenario 3: The busy season. A med spa does 40% of its annual revenue between January and June as patients prepare for summer. A working capital loan in November funds the injectable inventory, extra injector hours, and marketing push that make the season possible, and the facility is repaid from peak-season revenue by midsummer.
Scenario 4: The competitor's move. A competing practice across town launches a new skin-tightening treatment and starts advertising heavily. Rather than waiting a year to save for the same device, the owner finances it in weeks and holds her market position. In a segment where cosmetic surgery statistics show patients cluster around early adopters, speed was the whole game.
Scenario 5: The acquisition. An established practice has the chance to acquire a retiring colleague's practice - patient list, equipment, and trained staff included - for $450,000. An acquisition-focused term loan closes the deal in time, and the acquired revenue covers the payment from month one.
Industry estimates place the U.S. cosmetic surgery and aesthetics market at roughly $20 billion to $27 billion annually, with continued mid-to-high single-digit growth projected through the decade. The non-surgical segment is growing even faster, at an estimated 10% to 15% per year.
Minimally invasive treatments dominate by volume, led by botulinum toxin injections, hyaluronic acid fillers, and laser skin treatments. Among surgical procedures, liposuction, breast augmentation, abdominoplasty, eyelid surgery, and rhinoplasty consistently rank at the top of annual procedural statistics.
Startup costs vary widely by market and scope, but a realistic range is $500,000 to $1.5 million or more once you include the surgical suite build-out, accreditation, equipment, initial staffing, and marketing. Most new practices fund these costs with a combination of term loans and equipment financing.
The main options are equipment financing for devices and surgical equipment, term loans (including SBA loans) for build-outs and acquisitions, working capital loans for operating expenses, business lines of credit for flexible needs, and commercial real estate financing for purchasing a facility. Most growing practices use two or three of these together.
Yes. Equipment financing is one of the most common funding types in aesthetic medicine. Lasers, body-contouring platforms, surgical instruments, imaging systems, and exam equipment all qualify, and the equipment itself serves as collateral, which often makes approval faster and rates lower.
A personal credit score in the mid-600s or higher opens most financing programs, while scores above 700 qualify for the best rates. Medical practices often receive more flexible treatment than other industries at the same score because lenders view healthcare revenue as stable. Equipment financing can be accessible at lower scores because the equipment secures the deal.
Alternative lenders like Crestmont Capital typically deliver decisions within one business day and funding within a few days of approval. SBA loans take longer, often several weeks to a few months, in exchange for their lower rates and longer terms.
SBA loans offer attractive rates and terms of up to 10 years or more, and medical practices are among the most common recipients. The tradeoff is a slower, documentation-heavy process. They work best for large, planned projects like build-outs and acquisitions where timing is flexible.
A well-run single-surgeon practice commonly generates $1.5 million to $3 million or more per year, and top practices in major metros exceed $5 million. Revenue depends heavily on procedure mix; practices with strong non-surgical service lines often generate more consistent monthly cash flow than surgery-only practices.
Yes, though options narrow without operating history. New practices typically qualify through startup-friendly programs that weigh the surgeon's credentials, personal credit, and projected revenue more heavily. Equipment financing is often the most accessible first facility because the equipment itself provides collateral.
With financing, you own the equipment at the end of the term and build equity with each payment. With leasing, you pay for use of the equipment over the term and can upgrade to newer technology when it ends. Financing usually costs less overall; leasing keeps you current in device categories where platforms improve every few years.
Working capital covers operating expenses: payroll, rent, marketing campaigns, injectable and skincare inventory, device repairs, and bridging seasonal revenue gaps. It is shorter-term funding designed for speed and flexibility rather than long amortizations tied to a specific asset.
Structured correctly, financing should improve cash flow, not strain it. The key is matching the term to the asset and sizing the payment to the revenue the investment generates. A $3,000 monthly payment on a device producing $25,000 per month strengthens cash flow from the first month. Your lender should walk through this math with you before you sign.
Start with a short online application and recent business bank statements. Larger facilities may also ask for tax returns, financial statements, or an equipment quote. At Crestmont Capital, most applications are reviewed within hours, and a dedicated advisor walks you through the options.
Crestmont Capital is rated the #1 business lender in the U.S., with deep experience in medical and aesthetic practice funding. We offer fast decisions, flexible structures across equipment financing, term loans, and lines of credit, and a dedicated advisor who understands the economics of elective medicine from the first conversation.
Your Practice's Next Chapter Starts Here
Whether you need one device or a full build-out, get a fast decision from the #1 business lender in the U.S.
Apply Now →The plastic surgery statistics for 2026 describe an industry with rare momentum: a market measured in the tens of billions of dollars, more than 25 million procedures a year, a non-surgical segment growing at double-digit rates, and demographics that keep widening the patient base. The opportunity is real, and so is the capital required to capture it.
The practices that convert these industry numbers into practice growth share one habit: they invest ahead of demand rather than behind it. They add the device before the waiting list forms, build the suite before the schedule overflows, and fund the marketing before the competitor does. Financing is the tool that makes that timing possible.
If you are ready to put the 2026 plastic surgery statistics to work in your own practice, Crestmont Capital is ready to help. Our team understands aesthetic medicine, moves at the speed of your market, and structures financing around your cash flow. Apply today and find out what your practice qualifies for.
Disclaimer: The information provided in this article is for general educational purposes only and is not financial, legal, or tax advice. Funding terms, qualifications, and product availability may vary and are subject to change without notice. Crestmont Capital does not guarantee approval, rates, or specific outcomes. For personalized information about your business funding options, contact our team directly.